E-Case Report
Management of Refractory Telaprevir-Induced Dermatitis Using Oral Corticosteroids
Dermatitis por telaprevir: manejo con corticoides orales en casos refractarios
Leído
6746
Vecesse ha leído el artículo
2174
Total PDF
4572
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 44 | 8 | 52 |
| 2025 5 | 156 | 35 | 191 |
| 2025 4 | 171 | 27 | 198 |
| 2025 3 | 122 | 16 | 138 |
| 2025 2 | 120 | 20 | 140 |
| 2025 1 | 75 | 18 | 93 |
| 2024 12 | 81 | 26 | 107 |
| 2024 11 | 86 | 53 | 139 |
| 2024 10 | 59 | 36 | 95 |
| 2024 9 | 69 | 20 | 89 |
| 2024 8 | 112 | 59 | 171 |
| 2024 7 | 77 | 33 | 110 |
| 2024 6 | 102 | 28 | 130 |
| 2024 5 | 77 | 30 | 107 |
| 2024 4 | 69 | 25 | 94 |
| 2024 3 | 84 | 28 | 112 |
| 2024 2 | 77 | 34 | 111 |
| 2024 1 | 50 | 40 | 90 |
| 2023 12 | 60 | 18 | 78 |
| 2023 11 | 80 | 24 | 104 |
| 2023 10 | 63 | 18 | 81 |
| 2023 9 | 72 | 29 | 101 |
| 2023 8 | 39 | 24 | 63 |
| 2023 7 | 51 | 48 | 99 |
| 2023 6 | 59 | 22 | 81 |
| 2023 5 | 78 | 27 | 105 |
| 2023 4 | 70 | 25 | 95 |
| 2023 3 | 87 | 22 | 109 |
| 2023 2 | 66 | 16 | 82 |
| 2022 1 | 58 | 25 | 83 |
| 2022 12 | 54 | 45 | 99 |
| 2022 11 | 40 | 19 | 59 |
| 2022 10 | 26 | 22 | 48 |
| 2022 9 | 23 | 36 | 59 |
| 2022 8 | 27 | 31 | 58 |
| 2022 7 | 26 | 40 | 66 |
| 2022 6 | 18 | 21 | 39 |
| 2022 5 | 42 | 49 | 91 |
| 2022 4 | 44 | 36 | 80 |
| 2022 3 | 42 | 52 | 94 |
| 2022 2 | 36 | 21 | 57 |
| 2021 1 | 53 | 36 | 89 |
| 2021 12 | 34 | 29 | 63 |
| 2021 11 | 46 | 39 | 85 |
| 2021 10 | 57 | 40 | 97 |
| 2021 9 | 37 | 35 | 72 |
| 2021 8 | 30 | 18 | 48 |
| 2021 7 | 32 | 30 | 62 |
| 2021 6 | 36 | 28 | 64 |
| 2021 5 | 40 | 23 | 63 |
| 2021 4 | 76 | 54 | 130 |
| 2021 3 | 39 | 21 | 60 |
| 2021 2 | 54 | 31 | 85 |
| 2020 1 | 29 | 17 | 46 |
| 2020 12 | 31 | 12 | 43 |
| 2020 11 | 22 | 18 | 40 |
| 2020 10 | 23 | 15 | 38 |
| 2020 9 | 36 | 28 | 64 |
| 2020 8 | 30 | 32 | 62 |
| 2020 7 | 22 | 11 | 33 |
| 2020 6 | 28 | 25 | 53 |
| 2020 5 | 14 | 20 | 34 |
| 2020 4 | 30 | 11 | 41 |
| 2020 3 | 29 | 16 | 45 |
| 2020 2 | 1 | 6 | 7 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 8 | 1 | 9 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 4 | 1 | 5 |
| 2019 8 | 4 | 4 | 8 |
| 2019 7 | 4 | 11 | 15 |
| 2019 6 | 6 | 17 | 23 |
| 2019 5 | 4 | 37 | 41 |
| 2019 4 | 2 | 19 | 21 |
| 2019 3 | 4 | 7 | 11 |
| 2019 2 | 1 | 6 | 7 |
| 2019 1 | 5 | 0 | 5 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 2 | 0 | 2 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 1 | 1 |
| 2018 2 | 27 | 3 | 30 |
| 2018 1 | 34 | 15 | 49 |
| 2017 12 | 34 | 6 | 40 |
| 2017 11 | 24 | 4 | 28 |
| 2017 10 | 30 | 7 | 37 |
| 2017 9 | 30 | 1 | 31 |
| 2017 8 | 44 | 6 | 50 |
| 2017 7 | 42 | 2 | 44 |
| 2017 6 | 57 | 10 | 67 |
| 2017 5 | 49 | 14 | 63 |
| 2017 4 | 43 | 8 | 51 |
| 2017 3 | 25 | 26 | 51 |
| 2017 2 | 24 | 6 | 30 |
| 2016 1 | 21 | 6 | 27 |
| 2016 12 | 33 | 13 | 46 |
| 2016 11 | 40 | 12 | 52 |
| 2016 10 | 35 | 16 | 51 |
| 2016 9 | 0 | 1 | 1 |
| 2016 8 | 0 | 1 | 1 |
| 2016 7 | 9 | 2 | 11 |
| 2016 6 | 16 | 10 | 26 |
| 2016 5 | 10 | 5 | 15 |
| 2016 4 | 5 | 4 | 9 |
| 2016 3 | 5 | 2 | 7 |
| 2016 2 | 6 | 3 | 9 |
| 2015 1 | 9 | 7 | 16 |
| 2015 12 | 11 | 12 | 23 |
| 2015 11 | 24 | 1 | 25 |
| 2015 10 | 14 | 13 | 27 |
| 2015 9 | 8 | 5 | 13 |
| 2015 8 | 13 | 2 | 15 |
| 2015 7 | 64 | 12 | 76 |
| 2015 6 | 27 | 6 | 33 |
| 2015 5 | 25 | 4 | 29 |
| 2015 4 | 13 | 4 | 17 |
| 2015 3 | 8 | 2 | 10 |
| 2015 2 | 11 | 5 | 16 |
| 2015 1 | 8 | 4 | 12 |
| 2014 12 | 5 | 3 | 8 |
| 2014 11 | 10 | 3 | 13 |
Mostrar todo
